Test Price
2,800 AED✅ Home Collection Available
CYBA Gene Chronic Granulomatous Disease (CGD, Cytochrome b‑Negative) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل الحمض النووي للجين CYBA لمرض الورم الحبيبي المزمن (CGD، سلبية السيتوكروم ب) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
ملخص تنفيذي
✅ Accuracy Guarantee (ضمان الدقة)
99.9% Diagnostic Sensitivity – ISO 9001:2015 certified laboratory processing with NGS full‑gene sequencing and CNV analysis.
🚑 Premium Logistics (الخدمات اللوجستية المتميزة)
Hospital‑grade home collection (8 AM – 11 PM) using ISO‑certified cold‑chain transport and VIP mobile phlebotomy.
🩺 Clinical Guidance (الإرشاد السريري)
Telephonic post‑test interpretation with a clinical immunologist; mandatory genetic counselling session included.
🏥 Insurance (التأمين)
Direct billing verification via WhatsApp. Send your insurance card to +971 54 548 8731.
Book Now or Verify Insurance via WhatsApp
+971 54 548 8731Overview
The CYBA gene NGS test detects pathogenic mutations causing autosomal recessive chronic granulomatous disease (CGD) with cytochrome b‑negative phenotype. This advanced genetic analysis ensures precise diagnosis for recurrent infections and granuloma formation, guiding clinical management in UAE healthcare. يكشف اختبار NGS لجين CYBA عن الطفرات الممرضة المسببة لمرض الورم الحبيبي المزمن الصبغي المتنحي مع نمط سلبية السيتوكروم ب. يوفر هذا التحليل الجيني المتقدم تشخيصًا دقيقًا للعدوى المتكررة وتكوّن الأورام الحبيبية، مما يوجّه الرعاية السريرية في دولة الإمارات.
| Feature | Our Test – NGS CYBA Gene | Closest Alternative – DHR Flow Cytometry |
|---|---|---|
| Precision | 99.9% sensitivity – full gene sequencing + CNV detection | ~95% for functional defect; cannot identify carrier status or specific mutation |
| Methodology | Next Generation Sequencing (NGS), Sanger confirmation | Dihydrorhodamine (DHR) flow cytometry |
| Turnaround Time | 3–4 Weeks | 2–3 Days |
| Price | 2,800 AED | ~1,200 AED |
| Clinical Utility | Definitive molecular diagnosis, family screening, prenatal testing | First‑line screening for CGD; requires genetic test for confirmation |
Physician Insight & Safety Protocol
“As a clinical immunologist, I emphasise that genetic testing for CYBA mutations must be interpreted alongside clinical findings and neutrophil oxidative burst assays. No single test defines CGD; a multidisciplinary approach ensures accurate diagnosis and appropriate prophylactic treatment.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011
⚠️ Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Genetic results never override urgent clinical judgment.
Exclusion Criteria & Emergency Red Flags
- Active severe infection requiring hospitalisation — postpone testing until stable.
- Home collection not recommended for infants <6 months or patients with difficult venous access.
- Neonatal screening without family history of CGD is not validated; discuss with a geneticist.
- ER Red Flags: Sudden shortness of breath, high fever with abscess formation, signs of septic shock — seek emergency care immediately.
Patient FAQ & Clinical Guidance
1. What exactly does this CYBA gene test detect?
This test detects pathogenic mutations in the CYBA gene, confirming autosomal recessive chronic granulomatous disease (CGD) with cytochrome b deficiency, enabling targeted prophylaxis.
يكشف هذا الاختبار عن الطفرات الممرضة في جين CYBA، مما يؤكد مرض الورم الحبيبي المزمن الصبغي المتنحي مع نقص السيتوكروم ب، مما يتيح العلاج الوقائي الموجه.
2. How should I prepare for the test?
No special preparation is required; you can eat, drink, and take medications normally before blood collection.
لا يلزم تحضير خاص؛ يمكنك تناول الطعام والشراب وتناول الأدوية بشكل طبيعي قبل سحب الدم.
3. When will I receive my results and genetic counselling?
Results are delivered within 3 to 4 weeks, and a mandatory post‑ genetic counselling session will be scheduled to interpret findings for your family.
تصل النتائج خلال 3 إلى 4 أسابيع، وسيتم تحديد موعد لجلسة استشارة وراثية إلزامية بعد الاختبار لتفسير النتائج لك ولعائلتك.
🔬 ISO 9001:2015 Certified Laboratory
Certificate: INT/EGQ/2509DA/3139 – All processing adheres to Federal Decree‑Law No. 41 of 2024, UAE CDS Law 2026, and PDPL data privacy.
Facility License: 9834453 | Home collection: 8 AM – 11 PM daily.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians